Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
4.150
-0.180 (-4.16%)
At close: Apr 28, 2025, 4:00 PM
4.170
+0.020 (0.48%)
After-hours: Apr 28, 2025, 4:40 PM EDT
Company Description
Basel Medical Group Ltd engages in the provision of healthcare services in Singapore.
The company offers general and subspecialized orthopedic, trauma, sports medicine, and neurosurgical services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures.
Its services also include consultation, medical diagnosis, and medical and surgical treatments for orthopedic, trauma, sports medicine, and neurological conditions.
The company was incorporated in 2023 and is based in Singapore.
Basel Medical Group Ltd
| Country | Singapore |
| Founded | 2001 |
| IPO Date | Feb 25, 2025 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 32 |
| CEO | Wai Man Cheung |
Contact Details
Address: 600 North Bridge Road, #12-02/03 Singapore, 188778 Singapore | |
| Phone | 65 6291 9188 |
| Website | baselmedical.com |
Stock Details
| Ticker Symbol | BMGL |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | SGD |
| IPO Price | $4.00 |
| CIK Code | 0002004489 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Raymond Wai Man Cheung | Director and Chief Executive Officer |
| Jianing Lu | Director and Chief Financial Officer |
| Vincent Wee Keong Teo | Chief Partnership Officer |
| Darren Yen Feng Chhoa | Chief Health Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 21, 2025 | 6-K | Report of foreign issuer |
| Apr 11, 2025 | 6-K | Report of foreign issuer |
| Apr 4, 2025 | 6-K | Report of foreign issuer |
| Mar 25, 2025 | 6-K | Report of foreign issuer |
| Mar 19, 2025 | 6-K | Report of foreign issuer |
| Mar 6, 2025 | 6-K | Report of foreign issuer |
| Mar 3, 2025 | 6-K | Report of foreign issuer |
| Feb 28, 2025 | 6-K | Report of foreign issuer |
| Feb 25, 2025 | 424B4 | Prospectus |
| Feb 25, 2025 | 424B4 | Prospectus |